Table 1 Demographic and clinical characteristics of the study cohort
Variable | Total (n, F%) | SR group (n, F%) | NR group (n, F%) |
|---|---|---|---|
Total | 120 (100.0) | 45 (37.5) | 75 (62.5) |
Gender | |||
Male | 90 (75.0) | 32 (71.1) | 51 (68.0) |
Female | 30 (25.0) | 13 (28.9) | 24 (32.0) |
Age (in years) | |||
0–20 | 22 (18.3) | 5 (11.1) | 17 (22.7) |
21–60 | 89 (74.2) | 38 (84.5) | 51 (68.0) |
above 60 | 9 (7.5) | 2 (4.4) | 7 (9.3) |
Malaria relapse | |||
1 episode | 43 (35.8) | 43 (95.6) | – |
2 episodes | 1 (0.8) | 1 (2.2) | – |
3 episodes | 1 (0.8) | 1 (2.2) | – |
Infection sourcea | |||
Myanmar | 117 (97.5) | 42 (93.4) | 75 (100.0) |
Africa | 1 (0.8) | 1 (2.2) | – |
Yunnan indigenous | 2 (1.7) | 2 (4.4) | – |